Archive:
Aug 6, 2025, 12:00 AM
Novel patient-derived primary cell line MelT79 represents valuable model for understanding cutaneous melanoma heterogeneity, progression, and resistance mechanisms
Introduction: Cutaneous melanoma (CM) is an aggressive form of skin cancer, with rising incidence and poor prognosis at advanced stages. While early-stage CM typically carries a favorable prognosis, a…